The project IMPACT experience to date: increasing minority participation and awareness of clinical trials.

J Natl Med Assoc

National Medical Association, Project IMPACT, Washington, DC 20001, USA.

Published: February 2008

Objective: This study evaluated activities of Project IMPACT (Increase Minority Participation and Awareness of Clinical Trials), a National Medical Association (NMA) project chartered to identify ways to increase minority physician and patient involvement in clinical trials. Project IMPACT included physician education and training workshops, establishment of a physician-investigator database and other activities to facilitate minority-physician clinical trial participation.

Methods: A descriptive survey was used. The survey was distributed to 542 African-American physicians. Physicians were queried about prior involvement in clinical research, barriers and facilitators to clinical trial participation by patients and physicians, and perceptions regarding Project IMPACT.

Results: Two-hundred physicians responded to the survey. Common practice characteristics were self-employment (51%), solo practice (39%) and office based (58%). Prior involvement in clinical trials was generally low. Barriers to participation included lack of awareness of clinical trial opportunities and lack of resources to conduct clinical trials. However, most respondents had referred patients to clinical trials. Project IMPACT participants who responded were highly satisfied with the project.

Conclusions: Minority physicians are interested in participating in clinical trials. However, multiple barriers, including lack of awareness and lack of access to clinical research coordinators, continue to exist and must be addressed. Clinical trials training programs alone are not enough.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0027-9684(15)31206-2DOI Listing

Publication Analysis

Top Keywords

clinical trials
32
project impact
16
clinical
13
awareness clinical
12
involvement clinical
12
clinical trial
12
minority participation
8
participation awareness
8
trials
8
increase minority
8

Similar Publications

The incidence of chronic enteropathies (CE), in particular food-responsive enteropathies (FRE) in dogs, is on the rise in veterinary practice. The symptoms of these digestive disorders cannot be alleviated with the use of commercial hypoallergenic feeds. The applicability of novel materials in hypoallergenic dog feeds is limited, and edible insects could pose a viable alternative.

View Article and Find Full Text PDF

This study aims to determine the effect and equity outcomes of smoking prevention or smoking cessation interventions for children and adolescents involving parents. A systematic literature search was conducted between 24 November 2022 and 27 November 2023 in PubMed, Medline, Web of Science, Embase, PsycINFO, Google Scholar, ClinicalTrials.gov, EU Clinical Trials Register, and the WHO international clinical trials registry.

View Article and Find Full Text PDF

Background: Recently, there has been a surge in virtual reality (VR)-based training for upper limb (UL) rehabilitation, which has yielded mixed results. Therefore, we aimed to explore the effects of conventional therapy combined with VR-based training on UL dysfunction during post-stroke rehabilitation.

Methods: Studies published in English before May 2023 were retrieved from PubMed, Embase, and the Cochrane Library.

View Article and Find Full Text PDF

Background: Myocardial infarction with no obstructive coronary arteries (MINOCA), and ischemia with no obstructive coronary arteries (INOCA), are female-predominant conditions; clinical trials are lacking to guide medical management for the common underlying vasomotor etiologies. Data on long-term outcomes of (M)INOCA patients following attendance at a women's heart centre (WHC) are lacking.

Methods: Women diagnosed with MINOCA (n = 51) or INOCA (n = 112) were prospectively followed for 3 years at the Leslie Diamond WHC (LDWHC) in Vancouver.

View Article and Find Full Text PDF

Prognostic and Predictive Biomarkers of Oligometastatic NSCLC: New Insights and Clinical Applications.

JTO Clin Res Rep

December 2024

Department of Pulmonary Diseases, GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.

This review discusses the current data on predictive and prognostic biomarkers in oligometastatic NSCLC and discusses whether biomarkers identified in other stages and widespread metastatic disease can be extrapolated to the oligometastatic disease (OMD) setting. Research is underway to explore the prognostic and predictive value of biological attributes of tumor tissue, circulating cells, the tumor microenvironment, and imaging findings as biomarkers of oligometastatic NSCLC. Biomarkers that help define true OMD and predict outcomes are needed for patient selection for oligometastatic treatment, and to avoid futile treatments in patients that will not benefit from locoregional treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!